Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

12-Month Lobbying Summary - In-house Organization

Innovative Medicines Canada/Médicaments novateurs Canada / Bettina Hamelin, President

Address, activities & membership

Innovative Medicines Canada / Médicaments novateurs Canada - Address, activities & membership

Address:

55 Metcalfe St.
Suite 1220
Ottawa, ON  K1P 6L5
Canada

Telephone number: 343-999-2112

  • Contact information in previous versions
    • 55 Metcalfe St.
      Suite 1220
      Ottawa, ON  K1P 6L5
      Canada

      Telephone number: 613-236-0455

    • 55 Metcalfe St.
      Suite 1220
      Ottawa, ON  K1P 6L5
      Canada

      Telephone number: 613-236-0455  Ext. 725

      Fax number: 613-236-6756  

    • 55 Metcalfe St.
      Suite 1220
      Ottawa, ON  K1P 6L5
      Canada

      Telephone number: 613-236-0455  Ext. 425

      Fax number: 613-236-6756  

    • 55 Metclafe Street
      Suite 1220
      Ottawa, ON  K1P 6L5
      Canada

      Telephone number: 613-236-0455

      Fax number: 613-236-6756  

    • 55 Metcalfe Street
      Suite 1220
      Ottawa, ON  K1P 6L5
      Canada

      Telephone number: 613-236-0455  Ext. 425

      Fax number: 613-236-6756  

    • 55 METCALFE STREET, SUITE 1220
      OTTAWA, ON  K1P 6L5
      Canada

      Telephone number: 613-236-0455

      Fax number: 613-236-6756  

    • 1220 - 55 METCALFE STREET
      OTTAWA, ON  K1P 6L5
      Canada

      Telephone number: 613-236-0455

      Fax number: 613-236-7919  


Description of the organization's activities:
Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry. We help our members discover, develop, and deliver innovative medicines and vaccines. Our membership consists of more than 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines. Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system. We aim to achieve these goals by forming effective alliances and supporting policies, improving Canada’s regulatory environment, widen access to innovative medicines and protect intellectual property.

  • Descriptions of the organization's activity in previous versions:
    • Canada’s Research-Based Pharmaceutical Companies (Rx&D) is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents the men and women working for more than 50 member companies which invest more than $1 billion in research and development each year to fuel Canada’s knowledge-based economy, contributing over $3 billion to the Canadian economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, private payers, healthcare professionals and stakeholders in a highly ethical manner.
    • Canada’s Research-Based Pharmaceutical Companies (Rx&D) is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents the men and women working for more than 50 member companies and invests more than $1 billion in research and development each year to fuel Canada’s knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.
    • Canada’s Research-Based Pharmaceutical Companies (Rx&D) is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada’s knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.
    • Canada's Research-Based Pharmaceutical Companies (Rx&D) is the industry association of Canada's research-based pharmaceutical industry. The companies that make up the membership of Rx&D are engaged in the research and development, production, marketing, and servicing of prescription and non-prescription pharmaceutical products. Rx&D members employ more than 15,000 people across Canada. Comprised of companies of all sizes, Rx&D's membership reflects the international scope of the pharmaceutical industry and includes the Canadian operations of domestic firms. As well as those with headquarters in other countries, Rx&D membership is currently made up of approximately 50 member companies.
    • Canada's Research-Based Pharmaceutical Companies (Rx&D) is the industry association of Canada's research-based pharmaceutical industry. The companies that make up the membership of Rx&D are engaged in the research and development, production, marketing, and servicing of prescription and non-prescription pharmaceutical products. Rx&D members employ more than 22,000 people across Canada. Comprised of companies of all sizes, Rx&D's membership reflects the international scope of the pharmaceutical industry and includes the Canadian operations of domestic firms. As well as those with headquarters in other countries, Rx&D membership is currently made up of approximately 50 member companies.
    • Canada's Research-Based Pharmaceutical Companies (Rx&D) is the industry association of Canada's research-based pharmaceutical industry. The companies that make up the membership of Rx&D are engaged in the research and development, production, marketing, and servicing of prescription and non-prescription pharmaceutical products. Rx&D members employ more than 22,000 people accross Canada. Comprised of companies of all sizes, Rx&D's membershio reflects the international scope of the pharmaceutical industry and includes the Canadian operations of domestic firms. As well as those with headquarters in other countries, Rx&D membership is currently made up of approximately 50 member companies.
    • CANADA'S RESEARCH-BASED PHARMACEUTICAL INDUSTRY (RX&D) IS THE ASSOCIATION OF CANADA'S RESEARCH-BASED PHARMACEUTICAL INDUSTRY. THE COMPANIES THAT MAKE UP THE MEMBERSHIP OF RX&D ARE ENGAGED IN THE RESEARCH AND DEVELOPMENT, PRODUCTION, MARKETING, AND SERVICING OF PRESCRIPTION AND PROFESSIONAL NON-PRESCRIPTION PHARMACEUTICALS. RX&D MEMBERS EMPLOY MORE THAN 23,000 PEOPLE ACROSS CANADA. COMPRISED OF COMPANIES OF ALL SIZED, RX&D MEMBERSHIP REFLECTS THE INTERNATIONAL SCOPE OF TODAY'S MODERN PHARMACEUTICAL INDUSTRY AND INCLUDES THE CANADIAN OPERATIONS OF DOMESTIC FIRMS. AS WELL AS THOSE WITH HEADQUARTERS IN OTHER COUNTRIES, RX&D MEMBERSHIP IS CURRENTLY MADE UP OF 53 MEMBER COMPANIES.
    • CANADA'S RESEARCH-BASED PHARMACEUTICAL INDUSTRY (RX&D) IS THE ASSOCIATION OF CANADA'S RESEARCH-BASED PHARMACEUTICAL INDUSTRY. THE COMPANIES THAT MAKE UP THE MEMBERSHIP OF RX&D ARE ENGAGED IN THE RESEARCH AND DEVELOPMENT, PRODUCTION, MARKETING, AND SERVICING OF PRESCRIPTION AND PROFESSIONAL NON-PRESCRIPTION PHARMACEUTICALS. RX&D MEMBERS EMPLOY MORE THAN 18,000 PEOPLE ACROSS CANADA. COMPRISED OF COMPANIES OF ALL SIZES, RX&D MEMBERSHIP REFLECTS THE INTERNATIONAL SCOPE OF TODAY'S MODERN PHARMACEUTICAL INDUSTRY AND INCLUDES THE CANADIAN OPERATIONS OF DOMESTIC FIRMS, AS WELL AS THOSE WITH HEADQUARTERS IN OTHER COUNTRIES. RX&D MEMBERSHIP IS CURRENTLY MADE UP OF 59 MEMBER COMPANIES.

Organization's membership or classes of membership:
(a) Full Membership: Full membership is open to innovative pharmaceutical Persons which research, develop, manufacture and/or distribute pharmaceutical prescription preparations under their own labels in Canada. (b) Biopharmaceutical Membership: Biopharmaceutical membership is open to Persons who are engaged, in research and development of pharmaceutical products and/or biopharmaceutical health care products with the aim of producing, manufacturing or distributing the same under its own label. (c) Medical Research Affiliate Membership: Medical research affiliate membership is open to non-profit organizations engaged in research which have a relationship or are connected with hospitals, universities, research institutes, recognized health/disease organizations, or divisions or units thereof, whose membership, in the determination of the Board, would be consistent with the objects of the Association and would enhance the ability of the Association to attain such objects, and who are engaged in health research. (d) Associate Membership: Associate membership is open to Persons who do not qualify under any of the foregoing membership categories and whose membership, in the determination of the Board, would be consistent with the objects of the Association and would enhance the ability of the Association to attain such objects. Without limiting the generality of the foregoing, Associate Members may include contract research organizations, contract manufacturing organizations and clinical research organizations who supply goods and/or services to Full Members or Biopharmaceutical Members and other stakeholder groups which are appropriate in the determination of the Board.

  • Organization's memberships or classes of memberships in previous versions:
    • (a) Full Membership: Full membership is open to innovative pharmaceutical Persons which research, develop, manufacture and/or distribute pharmaceutical prescription preparations under their own labels in Canada. (b) Biopharmaceutical Membership: Biopharmaceutical membership is open to Persons who are engaged, for profit, in research and development of pharmaceutical products and/or biopharmaceutical health care products with the aim of producing, manufacturing or distributing the same under its own label. (c) Medical Research Affiliate Membership: Medical research affiliate membership is open to non-profit organizations engaged in research which have a relationship or are connected with hospitals, universities, research institutes, recognized health/disease organizations, or divisions or units thereof, whose membership, in the determination of the Board, would be consistent with the objects of the Association and would enhance the ability of the Association to attain such objects, and who are engaged in health research. (d) Associate Membership: Associate membership is open to Persons who do not qualify under any of the foregoing membership categories and whose membership, in the determination of the Board, would be consistent with the objects of the Association and would enhance the ability of the Association to attain such objects (»Associate Members«). Without limiting the generality of the foregoing, Associate Members may include contract research organizations, contract manufacturing organizations and clinical research organizations who supply goods and/or services to Full Members or Biopharmaceutical Members and other stakeholder groups.
    • (a) Full Membership: Full membership is open to innovative pharmaceutical Persons which research, develop, manufacture and/or distribute pharmaceutical prescription preparations under their own labels in Canada. (b) Biopharmaceutical Membership: Biopharmaceutical membership is open to Persons who are engaged, for profit, in research and development of pharmaceutical products and/or biopharmaceutical health care products with the aim of producing, manufacturing or distributing the same under its own label.(c) Medical Research Affiliate Membership: Medical research affiliate membership is open to non-profit organizations engaged in research which have a relationship or are connected with hospitals, universities, research institutes, recognized health/disease organizations, or divisions or units thereof, whose membership, in the determination of the Board, would be consistent with the objects of the Association and would enhance the ability of the Association to attain such objects, and who are engaged in health research.(d) Associate Membership: Associate membership is open to Persons who do not qualify under any of the foregoing membership categories and whose membership, in the determination of the Board, would be consistent with the objects of the Association and would enhance the ability of the Association to attain such objects (»Associate Members«). Without limiting the generality of the foregoing, Associate Members may include contract research organizations, contract manufacturing organizations and clinical research organizations who supply goods and/or services to Full Members or Biopharmaceutical Members and other stakeholder groups.
    • FULL MEMBERS-CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO REASEACH, DEVELOP, MANUFACTURE AND/OR DISTRIBUTE BRAND NAME PHARMACEUTICALS. RESEARCH ASSOCIATE MEMBERS - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO ARE ENGAGED FOR PROFIT IN RESEARCH AND DEVELOPMENT OF PHARMACEUTICAL PRODUCTS. MANUFACTURING AFFILIATE MEMBERSHIP - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO ARE ENGAGED IN CUSTOM MANUFACTURING OR CUSTOM PACKAGING, FOR OR SUPPLY PHARMACEUTICAL CHEMICALS TO FULL MEMBERS.
    • FULL MEMBERS - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO RESEARCH, DEVELOP, MANUFACTURE AND/OR DISTRIBUTE BRAND NAME PHARMACEUTICALS. RESEARCH ASSOCIATE MEMBERS - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO ARE ENGAGED FOR PROFIT IN RESEARCH AND DEVELOPMENT OF PHARMACEUTICAL PRODUCTS. MANUFACTURING AFFILIATE MEMBERSHIP - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO ARE ENGAGED IN CUSTOM MANUFACTURING OR CUSTOM PACKAGING, FOR OR SUPPLY PHARMACEUTICAL CHEMICALS TO FULL MEMBERS.

Public offices held: Emily Roome


Government funding

No government funding was received during the last completed financial year.

Public offices held: Lama Abi Khaled

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
Law Clerk
Federal Court of Canada, No branch or unit 		July 2013 to August 2014 Not a designated office
Senior Regulatory Officer
Patented Medicine Prices Review Board, Regulatory Affairs and Outreach 		December 2008 to June 2013 Not a designated office

Public offices held: Hugh Scott

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
Legislative Assistant to Albina Guarnieri, M.P. - Parliamentary Secretary to the Minister of Canadian Heritage
Canadian Heritage, Parliament Hill Office 		1994 to March 1998 Not a designated office

Public offices held: Michael Dietrich

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
Jr. Research Analyst
Industry Canada, Industrial Analysis 		2004 to 2004 Not a designated office

Public offices held: Hugh Scott

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
Legislative Assistant to Albina Guarnieri, M.P. - Parliamentary Secretary to the Minister of Canadian Heritage
Canadian Heritage, Parliament Hill Office 		1994 to March 1998 Not a designated office

Public offices held: Bettina Hamelin

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
Vice President, Research Partnerships
Council of Canada, Natural Sciences and Engineering Research Council of Canada 		August 2015 to July 2017 July 12, 2017

Public offices held: Ashley Bergwerff

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
Senior Advisor, Program Delivery
Health Canada, Office of Nutrition Policy and Promotion 		August 2020 to November 2020 Not a designated office

Public offices held: Declan Hamill

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
COSEP Student, Official Languages Commission
Official Language Commission, Language Commission 		1990 to 1991 Not a designated office

Public offices held: Sophie Normand

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
Social Media Coordinator
Senate of Canada, Communications Directorate 		November 2020 to April 2021 Not a designated office
Social Media and Special Projects Coordinator
Parliament of Canada, Office of the Speaker of the House of Commons 		November 2018 to August 2019 Not a designated office
Director of Events (acting)
Parliament of Canada, Office of the Speaker of the House of Commons 		September 2018 to November 2018 Not a designated office
Administrative Assistant
Parliament of Canada, Office of the Speaker of the House of Commons 		March 2017 to September 2018 Not a designated office
Summer Student
Parliament of Canada, Office of the Speaker of the House of Commons 		April 2016 to March 2017 Not a designated office
Page
Parliament of Canada, House of Commons 		August 2013 to August 2014 Not a designated office

Public offices held: Charles Brown

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
Labour Market Economic Analyst
Employment and Immigration Canada, Economic Services 		September 1989 to September 1992 Not a designated office

Public offices held: Jonathan Ballingall

List of Public Offices Held
Position Period Held Last Date Designated Public Office Held
Director of Operations
Foreign Affairs, Trade and Development of Canada, Office of the Minister of Foreign Affairs of Canada 		November 2014 to December 2015 December 4, 2015
Manager of Operations & Senior Special Assistant Regional Affairs, Appointments and NCC
Foreign Affairs, Trade and Development of Canada, Office of the Minister of Foreign Affairs of Canada 		October 2013 to November 2014 November 3, 2014
Special Assistant to the Minister
Foreign Affairs, Trade and Development of Canada, Office of the minister of Foreign Affairs of Canada 		June 2011 to October 2013 October 1, 2013

Date Modified: